Search research articles
Contact Us
Filters
Showing results (141-150 of 168) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer
John P Crown, Véronique Diéras, Elzbieta Staroslawska, et al.
Journal for Immunotherapy of Cancer
|
November 3, 2022
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Toni K Choueiri, Harriet Kluger, Saby George, et al.
The New England Journal of Medicine
|
June 7, 2011
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
Caroline Robert, Luc Thomas, Igor Bondarenko, et al.
Science Advances
|
September 13, 2024
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis
Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 25, 2019
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
Hyun Cheol Chung, Sarina A Piha-Paul, Jose Lopez-Martin, et al.
The Lancet. Oncology
|
September 13, 2020
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, et al.
Oncology
|
August 25, 2010
Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program
Ronald M Bukowski, Walter M Stadler, David F McDermott, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2017
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
Sandra P D'Angelo, James Larkin, Jeffrey A Sosman, et al.
Cancer
|
January 19, 2010
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Walter M Stadler, Robert A Figlin, David F McDermott, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 168) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer
John P Crown, Véronique Diéras, Elzbieta Staroslawska, et al.
Journal for Immunotherapy of Cancer
|
November 3, 2022
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Toni K Choueiri, Harriet Kluger, Saby George, et al.
The New England Journal of Medicine
|
June 7, 2011
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
Caroline Robert, Luc Thomas, Igor Bondarenko, et al.
Science Advances
|
September 13, 2024
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis
Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 25, 2019
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
Hyun Cheol Chung, Sarina A Piha-Paul, Jose Lopez-Martin, et al.
The Lancet. Oncology
|
September 13, 2020
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, et al.
Oncology
|
August 25, 2010
Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program
Ronald M Bukowski, Walter M Stadler, David F McDermott, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2017
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
Sandra P D'Angelo, James Larkin, Jeffrey A Sosman, et al.
Cancer
|
January 19, 2010
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Walter M Stadler, Robert A Figlin, David F McDermott, et al.
Page
of 17